GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (FRA:9O6) » Definitions » Loans Receivable

Molekule Group (FRA:9O6) Loans Receivable : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Loans Receivable?

Molekule Group's Loans Receivable for the quarter that ended in Jun. 2023 was €0.00 Mil.


Molekule Group Loans Receivable Historical Data

The historical data trend for Molekule Group's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Loans Receivable Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Loans Receivable
- - - -

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Molekule Group Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Molekule Group Loans Receivable Related Terms

Thank you for viewing the detailed overview of Molekule Group's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (FRA:9O6) Business Description

Traded in Other Exchanges
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Molekule Group (FRA:9O6) Headlines

No Headlines